Benign familial hematuria: genes and variants
Explore variant evidence for Benign familial hematuria across 2 analyzed proteins (COL4A3, COL4A4). Linked ClinVar records include 141 pathogenic or likely pathogenic variants, 216 variants of uncertain significance and 202 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Benign familial hematuria
COL4A3: Collagen alpha-3(IV) chain
It contributes to the alpha3-alpha4-alpha5 type IV collagen network that forms the specialized basement membrane of the renal glomerulus, cochlea, and eye. Pathogenic variants cause Alport-spectrum disease and thin-basement-membrane nephropathy, with variable kidney and hearing involvement.
76 ClinVar pathogenic / likely pathogenic and 168 uncertain variants in COL4A3 have source records linked to Benign familial hematuria. Association strength is not clinical gene validity.
COL4A4: Collagen alpha-4(IV) chain
It combines with the alpha3 and alpha5 chains to form the mature type IV collagen network of glomerular, cochlear, and ocular basement membranes. Pathogenic variants cause autosomal Alport-spectrum disease and can present with isolated persistent hematuria.
65 ClinVar pathogenic / likely pathogenic and 250 uncertain variants in COL4A4 have source records linked to Benign familial hematuria. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Benign familial hematuria
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| COL4A3 G532C | 532 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G532D | 532 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G730E | 730 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1207R | 1207 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1228D | 1228 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G65S | 65 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G314D | 314 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G65V | 65 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G318D | 318 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G336C | 336 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G452R | 452 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G493R | 493 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G520D | 520 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G715S | 715 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G736V | 736 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G777V | 777 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G795E | 795 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G883R | 883 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G922E | 922 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G997E | 997 | Cell attachment site | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1045V | 1045 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1137D | 1137 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1155S | 1155 | Cell attachment site | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1385E | 1385 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G143V | 143 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G149V | 149 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G240R | 240 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G252V | 252 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G305V | 305 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G451S | 451 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G527C | 527 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G533D | 533 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G551D | 551 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G855R | 855 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G864R | 864 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G870R | 870 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G1066V | 1066 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G490R | 490 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G695R | 695 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G985E | 985 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1104R | 1104 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1167R | 1167 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1207E | 1207 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1228R | 1228 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 L1598R | 1598 | Collagen IV NC1 | Pathogenic / likely pathogenic (★★) |
| COL4A3 C1616Y | 1616 | Collagen IV NC1 | Pathogenic / likely pathogenic (★★) |
| COL4A4 G68V | 68 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G161V | 161 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G252D | 252 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G698R | 698 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G1018R | 1018 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G55R | 55 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G115A | 115 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G439S | 439 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G593R | 593 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G619R | 619 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1003R | 1003 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1143R | 1143 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1418R | 1418 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G475A | 475 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
Showing 60 of 141.
Uncertain variants prioritized for review in Benign familial hematuria
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| COL4A4 G199R | 199 | Triple-helical region | Conflicting reports (★) | +7: G199V at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.967 |
| COL4A4 G1106D | 1106 | Triple-helical region | Conflicting reports (★) | +7: G1106S at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.967 |
| COL4A3 G532S | 532 | Triple-helical region | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; G532C at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.975 |
| COL4A4 G161R | 161 | Triple-helical region | Conflicting reports (★) | +6: G161V at the same position is pathogenic; REVEL 0.952 |
| COL4A4 G252S | 252 | Triple-helical region | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G252V at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.748 |
Which prediction tools work for Benign familial hematuria
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 100 out of 100
- MetaLR: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 100 out of 100
- phyloP: 99 out of 100
- MutPred: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 96 out of 100
- MetaSVM: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 94 out of 100
- Pangolin: 55 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 51 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Autosomal dominant Alport syndrome also has ClinVar records linked to COL4A3 variants; they fall partly in the same places as the Benign familial hematuria variants (131 pathogenic / likely pathogenic).
- Alport syndrome also has ClinVar records linked to COL4A3 variants; they fall mostly in different places as the Benign familial hematuria variants (128 pathogenic / likely pathogenic).
- Autosomal recessive Alport syndrome also has ClinVar records linked to COL4A3 variants; they fall mostly in different places as the Benign familial hematuria variants (32 pathogenic / likely pathogenic).
- Autosomal recessive Alport syndrome also has ClinVar records linked to COL4A4 variants; they fall partly in the same places as the Benign familial hematuria variants (99 pathogenic / likely pathogenic).
- Alport syndrome also has ClinVar records linked to COL4A4 variants; they fall partly in the same places as the Benign familial hematuria variants (57 pathogenic / likely pathogenic).
- Autosomal dominant Alport syndrome also has ClinVar records linked to COL4A4 variants; they fall partly in the same places as the Benign familial hematuria variants (6 pathogenic / likely pathogenic).
Diseases related to Benign familial hematuria
- Alport syndrome, also linked to COL4A3 and COL4A4
- Autosomal dominant Alport syndrome, also linked to COL4A3 and COL4A4
- Autosomal recessive Alport syndrome, also linked to COL4A3 and COL4A4
- Benign neonatal seizures, also linked to COL4A3 and COL4A4
- Polycystic kidney disease, also linked to COL4A4
- Nephrotic syndrome, also linked to COL4A4
- Focal segmental glomerulosclerosis, also linked to COL4A4
- Kidney disorder, also linked to COL4A3
Frequently asked questions
Which genes have records linked to Benign familial hematuria?
This view contains 2 analyzed proteins: COL4A3, COL4A4. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 141 pathogenic or likely pathogenic variants, 216 variants of uncertain significance and 202 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 5 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 597 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center